A lyophilised research vial carries more than freeze-dried powder. Its cake, declared excipients, label and batch documentation form a traceable record that laboratory researchers and materials managers rely on when stock is audited, relocated or rebuilt after a freezer event. Mannitol is one excipient that may appear in that record, and its declaration deserves attention before the freezer inventory is rebuilt rather than after the new stock list is signed off.
Research Sciences states in its FAQs that all peptides contain trace amounts of mannitol. The shop describes mannitol as an excipient that helps the vial not look empty, supports stability during lyophilisation, aids solubility and provides protection in storage. These are published explanations for a research-use-only item. The same FAQs stress that products are labelled “For Research Use Only – Not for Human Consumption” and are not for human or veterinary use; they are not medicines, medical devices, injectables, treatments or food supplements under UK law. Researchers should read the mannitol declaration as a documentation and handling matter, not as a clinical or therapeutic attribute.
Why Mannitol Is Declared in Lyophilised Research Vials
In a lyophilised research vial, the research compound is present alongside excipients that support freeze-drying and the stability of the dried cake. Mannitol is commonly used as a bulking agent and cryoprotectant; Research Sciences describes its trace presence as helping the vial not look empty, supporting stability during lyophilisation, aiding solubility and protecting the material in storage. For a materials manager, the key point is that mannitol is declared. A declared excipient is part of the product record and should be checked against the physical vial before an inventory rebuild proceeds.
Vial appearance alone is not a reliable identifier. A freeze-dried cake may look uniform, but its composition, batch history and documentation are specific to the vial. Research Sciences uses vial labels that combine the SKU code and expiry date, for example a reference in the format BPC10-03/27, and the shop says this reference links to the corresponding CoA. Researchers should quote that reference when contacting the shop about documentation. Vial cap colours and other packaging may vary; the shop states that cap colour is not an indicator of identity, analytical quality or manufacturing origin. Mannitol’s declared status therefore belongs in the same verification chain as the label reference and batch CoA.
The FAQs say a Certificate of Analysis is provided for every product, with HPLC testing for purity and identity, and that exact purity is stated on the CoA. Researchers should open and check the CoA that accompanies the specific batch rather than relying on a headline figure. The homepage’s “CoAs Janoshik Analytical Reports” wording should still be checked against the batch document. Restocked products may carry the same Internal Test Reference (ITR) as earlier stock; the shop explains that an ITR links to associated sample testing reports but does not confirm that separate deliveries come from the same production lot or have had separate independent testing. The excipient declaration should therefore be read alongside batch-specific documentation, not assumed from a previous inventory entry.
Rebuilding Freezer Inventory: Verifying Excipient Declarations and Batch Records
A freezer inventory rebuild can follow a freezer failure, relocation, stocktake, records migration or audit finding. In each case, the rebuild is a documentation exercise as much as a physical one. Before new stock records are created, vials should be matched to their labels, CoAs and any internal test references. The mannitol declaration should be checked at the same time. If a label or CoA is missing, the vial should be quarantined pending clarification rather than assigned to a new inventory line on the basis of appearance or an old spreadsheet.
ITR, cap colour and excipient checks
The FAQs note that restocked products may carry the same ITR as earlier stock, but this reference links to sample testing reports and does not confirm a shared production lot or separate independent testing. For a freezer rebuild, an ITR can help locate documentation but should not substitute for the batch CoA. Cap colour may vary between deliveries and should not be used to infer identity, quality or origin. Mannitol should be recorded as part of the declared product description without turning it into an identifier for a production lot. The vial label reference remains the practical key for correspondence with the shop.
Handling records should reflect the shop’s research-use-only guidance. Lyophilised peptides should be stored at –20°C or below, sealed with desiccant and protected from moisture, heat and light. Repeated freeze–thaw cycles should be avoided. Vials should be allowed to reach room temperature before opening, and work should take place in a clean environment with only the amount required for the experiment removed. Reconstituted peptides are less stable and should be stored at 2–8°C for short-term laboratory use. Any reconstitution should stay inside an in-vitro laboratory workflow, with diluent volume and target concentration recorded for the assay; the free reconstitution calculator is for laboratory research use only and must not be used for human or veterinary dosing. When matching physical vials to documentation, researchers may consult the product pages and batch records for Peptides uk catalogue items, but the label and CoA for the specific vial remain the primary references.
Practical Steps for Materials Managers Rebuilding Frozen Stock Records
Before the new inventory is finalised, materials managers should create a verification line for each vial: label reference, product name, batch CoA, ITR where present, declared excipient notes, storage location and freeze–thaw history. The mannitol declaration should be copied from the shop’s published FAQ or batch documentation exactly as stated, without adding assumptions about concentration or function beyond what is documented. If the label is damaged or the CoA cannot be located, the vial should be held pending a documentation check rather than allocated to a new experiment. This matters when vials have been moved or re-labelled.
Storage conditions should be verified with the paperwork. The shop’s quick guide says lyophilised peptides should be kept at –20°C or below, sealed with desiccant and protected from moisture, heat and light; reconstituted peptides should be kept at 2–8°C for short-term laboratory use. Inventory records should distinguish between sealed lyophilised vials and any vials that have been opened or reconstituted. The shop does not supply blended peptides and recommends buying peptides individually and combining only within a controlled experimental design, so each vial should be recorded as an individual stock item. All products are for controlled laboratory and analytical research only; they are not for human or veterinary use, consumption, administration or clinical application. Any published purity or delivery wording should be treated as current site text and reconfirmed on the live page and batch CoA.
Where a discrepancy is found, quote the vial label reference in correspondence with the supplier and check the mannitol declaration against the shop’s current FAQ wording. The rebuilt inventory should leave a clear trail from the physical vial to its label, CoA and ITR. Before sign-off, record the declared excipient exactly as documented and note any missing or inconsistent paperwork for follow-up. That record then supports lawful use, safe handling, storage and disposal under the purchaser’s own COSHH and laboratory safety arrangements.
